Acute Myeloid Leukemia Reported 32 Months After Icotinib Therapy for EGFR-Mutated Lung Cancer
A case report and literature review describe acute myeloid leukemia developing 32 months into icotinib therapy for EGFR-mutated lung cancer, ...
A case report and literature review describe acute myeloid leukemia developing 32 months into icotinib therapy for EGFR-mutated lung cancer, ...
A meta-analysis of fourteen retrospective cohort studies associates TACE-HAIC combined with targeted therapy and immune checkpoint inhibitors with improved survival ...
A case report in Annals of Hematology describes a 56-year-old man with newly diagnosed acute undifferentiated leukemia who achieved complete ...
A subgroup analysis of the phase 3 RASolute 302 trial presented at ESMO found the targeted RAS inhibitor daraxonrasib extended ...
A retrospective MD Anderson cohort of nine adults with NF1-associated high-grade glioma found partial radiographic responses in two patients treated ...
An editorial summarizing eight contributions describes cancer drug resistance as an adaptive process involving genetic, epigenetic, metabolic, signalling and microenvironmental ...
A narrative review links heat shock proteins to gastric cancer invasiveness, resistance and immune modulation, but finds that most therapeutic ...
A systematic review of 200 publications found the clearest clinical evidence for tyrosine kinase inhibitors in canine mast cell tumours, ...
A 2026 literature review synthesizes clinical, diagnostic, molecular and therapeutic evidence on transformation from non–small cell lung cancer to small ...
A 2026 review summarizes recurrent molecular alterations, immune suppression, multimodal imaging and current treatment strategies for primary cardiac angiosarcoma, a ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine